If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 15.50
Ask: 16.50
Change: -0.75 (-4.48%)
Spread: 1.00 (6.452%)
Open: 16.75
High: 16.75
Low: 15.75
Prev. Close: 16.75
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Nominated Adviser and Broker

24 May 2023 07:00

RNS Number : 3998A
Inspiration Healthcare Group PLC
24 May 2023
 

24 May 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Appointment of Nominated Adviser and Broker

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in class, specialist neonatal intensive care medical devices, announces the appointment of Liberum Capital Limited ("Liberum") as the Company's Nominated Adviser and sole Broker with immediate effect.

 

Inspiration Healthcare Group plc

Tel: +44 (0)330 175 0000

 

Neil Campbell, Chief Executive Officer

Paul Bergin, Interim Chief Financial Officer

 

Liberum (Nominated Adviser & Broker)

Tel: +44 (0)20 3100 2000

Phil Walker, Richard Lindley, William Hall, Will King

Walbrook PR Ltd (Media and Investor Relations)

Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com

Anna Dunphy

Mob: +44 (0) 7876 741 001

Stephanie Cuthbert

Mob: +44 (0) 7796 794 663

Louis Ashe-Jepson

Mob: +44 (0) 7747 515 393

 

 

About Inspiration Healthcare Group plc

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

 

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

 

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

 

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

 

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex). The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

 

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPUOOVROAUVUAR
Date   Source Headline
5th Sep 20197:00 amRNSProposed Acquisition of Vio Holdings and Placing
15th Aug 20197:00 amRNSTrading Update
27th Jun 20191:16 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
28th May 20197:00 amRNSUpdate regarding NPXe plc
23rd May 20197:00 amRNSNotice of AGM
30th Apr 20197:00 amRNSPreliminary Results
23rd Apr 20197:00 amRNSWinning of Queen's Award for Enterprise
20th Mar 20197:00 amRNSCertification received to the new MDSAP
14th Mar 20197:00 amRNSLargest Ever Patient Warming System Order
22nd Feb 20197:00 amRNSTrading Update and Notice of Results
11th Feb 201911:01 amRNSPrice Monitoring Extension
25th Jan 20197:00 amRNSGrowth & Innovation Forum 2019
18th Dec 20187:00 amRNSLicensing agreement with US University
7th Dec 20187:00 amRNSStatement re potential IPO of NeuroproteXeon
8th Nov 20187:00 amRNSGrant of Options
2nd Oct 20187:00 amRNSInterim Results
30th Aug 20187:00 amRNSInvestor Evening - 4 October 2018
24th Aug 20187:00 amRNSTrading Update and Notice of Results
3rd Jul 20187:00 amRNSRenewal of Tecotherm and Micrel Agreements
15th Jun 201812:30 pmRNSResult of AGM
15th Jun 20187:00 amRNSAGM Statement
7th Jun 20187:00 amRNSPotential IPO of NeuroproteXeon Limited
18th May 201811:59 amRNSPosting of Annual Report and Notice of AGM
9th May 20183:15 pmRNSNeuroproteXeon and Linde Distribution Partnership
24th Apr 20187:00 amRNSPreliminary Results
21st Feb 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSCFM unit granted CE mark and Neotech Agreement.
9th Jan 20187:00 amRNSAppointment of Head of Marketing
14th Nov 20177:00 amRNSEnhanced LifeStart launched at MEDICA
9th Nov 20177:00 amRNSGrant of Options
17th Oct 20179:15 amRNSCorrected rPAP Driver Unit Granted CE mark notice
17th Oct 20177:00 amRNSNeonatal Resuscitation Driver Granted CE mark
3rd Oct 20177:00 amRNSNeuroproteXeon and Mallinckrodt licence agreement
26th Sep 20177:00 amRNSInterim Results
11th Sep 20177:00 amRNSTR1 Notification of Major Interest in Shares
31st Aug 20177:00 amRNSOperational Appointments
25th Aug 20177:00 amRNSTrading Update and Notice of Results
17th Aug 20177:00 amRNSCapital Reduction
14th Aug 20177:00 amRNSInvestors Open Day
31st Jul 20172:45 pmRNSCapital Reduction
30th Jun 201712:01 pmRNSResult of AGM
30th Jun 20177:00 amRNSAGM Statement
19th May 20177:00 amRNSPosting of Annual Report and Notice of AGM
3rd May 20177:00 amRNSPreliminary Results
4th Apr 20174:25 pmRNSNotice of Results
4th Apr 20172:38 pmRNSHolding(s) in Company
6th Feb 20177:00 amRNSNew Corporate Office & Change of Registered Office
5th Dec 20161:05 pmRNSRevised Notification of Major Interest In Shares
28th Nov 201610:50 amRNSTR1 Notification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.